Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)

Completed

Conditions studied: Baseline Epidemiologic Assessment

In brief

The main objectives of this study are to provide surveillance/descriptive data to (a) assess utilization of MorphaBond ER and selected comparators overall and by age group and census regions using nationally-projected quarterly drug dispensing data and (b) assess the scope and pattern of abuse and clinical outcomes for MorphaBond ER using nationally representative data or data from large geographic areas in different populations. Findings of this study will support the design of formal epidemiology assessment of the risks of addiction, overdose, and death outcomes associated with MorphaBond ER and appropriate comparators in the future.

Key facts

Study ID

NCT04033094

Run by

Daiichi Sankyo

People needed

17566

Starts

2017-10-16

Expected to finish

2020-12-31

Last updated by the study team

2021-03-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female
• MorphaBond ER users or relevant comparator users

You may not qualify if…

• Not applicable

Where it is running

• Daiichi Sankyo, Inc. — Basking Ridge, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.